92 related articles for article (PubMed ID: 22990051)
1. Soluble inflammation markers in nasal lavage from CF patients and healthy controls.
Beiersdorf N; Schien M; Hentschel J; Pfister W; Markert UR; Mainz JG
J Cyst Fibros; 2013 May; 12(3):249-57. PubMed ID: 22990051
[TBL] [Abstract][Full Text] [Related]
2. Influences of nasal lavage collection-, processing- and storage methods on inflammatory markers--evaluation of a method for non-invasive sampling of epithelial lining fluid in cystic fibrosis and other respiratory diseases.
Hentschel J; Müller U; Doht F; Fischer N; Böer K; Sonnemann J; Hipler C; Hünniger K; Kurzai O; Markert UR; Mainz JG
J Immunol Methods; 2014 Feb; 404():41-51. PubMed ID: 24370751
[TBL] [Abstract][Full Text] [Related]
3. Colonization of CF patients' upper airways with S. aureus contributes more decisively to upper airway inflammation than P. aeruginosa.
Janhsen WK; Arnold C; Hentschel J; Lehmann T; Pfister W; Baier M; Böer K; Hünniger K; Kurzai O; Hipler UC; Mainz JG
Med Microbiol Immunol; 2016 Oct; 205(5):485-500. PubMed ID: 27377929
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from cystic fibrosis patients during intravenous antibiotic treatment.
Hentschel J; Jäger M; Beiersdorf N; Fischer N; Doht F; Michl RK; Lehmann T; Markert UR; Böer K; Keller PM; Pletz MW; Mainz JG
BMC Pulm Med; 2014 May; 14():82. PubMed ID: 24885494
[TBL] [Abstract][Full Text] [Related]
5. Composition of nasal airway surface liquid in cystic fibrosis and other airway diseases determined by X-ray microanalysis.
Vanthanouvong V; Kozlova I; Johannesson M; Nääs E; Nordvall SL; Dragomir A; Roomans GM
Microsc Res Tech; 2006 Apr; 69(4):271-6. PubMed ID: 16586482
[TBL] [Abstract][Full Text] [Related]
6. Nasal lavage microbiome, but not nasal swab microbiome, correlates with sinonasal inflammation in children with cystic fibrosis.
Chung J; Boutin S; Frey DL; Joachim C; Mall MA; Sommerburg O
J Cyst Fibros; 2024 Mar; 23(2):226-233. PubMed ID: 38199892
[TBL] [Abstract][Full Text] [Related]
7. Protease-antiprotease imbalances differ between Cystic Fibrosis patients' upper and lower airway secretions.
Hentschel J; Fischer N; Janhsen WK; Markert UR; Lehmann T; Sonnemann J; Böer K; Pfister W; Hipler UC; Mainz JG
J Cyst Fibros; 2015 May; 14(3):324-33. PubMed ID: 25286826
[TBL] [Abstract][Full Text] [Related]
8. Nasal wash as an alternative to bronchoalveolar lavage in detecting early pulmonary inflammation in children with cystic fibrosis.
Pitrez PM; Brennan S; Turner S; Sly PD
Respirology; 2005 Mar; 10(2):177-82. PubMed ID: 15823182
[TBL] [Abstract][Full Text] [Related]
9. Molecular markers of acute upper airway inflammation in workers exposed to fuel-oil ash.
Woodin MA; Hauser R; Liu Y; Smith TJ; Siegel PD; Lewis DM; Tollerud DJ; Christiani DC
Am J Respir Crit Care Med; 1998 Jul; 158(1):182-7. PubMed ID: 9655727
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive assessment of upper and lower airway infection and inflammation in CF patients.
Fischer N; Hentschel J; Markert UR; Keller PM; Pletz MW; Mainz JG
Pediatr Pulmonol; 2014 Nov; 49(11):1065-75. PubMed ID: 24464968
[TBL] [Abstract][Full Text] [Related]
11. Divergent dynamics of inflammatory mediators and multiplex PCRs during airway infection in cystic fibrosis patients and healthy controls: Serial upper airway sampling by nasal lavage.
Erdmann N; Schilling T; Hentschel J; Lehmann T; von Bismarck P; Ankermann T; Duckstein F; Baier M; Zagoya C; Mainz JG
Front Immunol; 2022; 13():947359. PubMed ID: 36466839
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of chronic sinus diseases by measurement of inflammatory mediators.
Van Zele T; Claeys S; Gevaert P; Van Maele G; Holtappels G; Van Cauwenberge P; Bachert C
Allergy; 2006 Nov; 61(11):1280-9. PubMed ID: 17002703
[TBL] [Abstract][Full Text] [Related]
13. Cytokines in nasal lavages and plasma and their correlation with clinical parameters in cystic fibrosis.
Paats MS; Bergen IM; Bakker M; Hoek RA; Nietzman-Lammering KJ; Hoogsteden HC; Hendriks RW; van der Eerden MM
J Cyst Fibros; 2013 Dec; 12(6):623-9. PubMed ID: 23751406
[TBL] [Abstract][Full Text] [Related]
14. IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis.
Derycke L; Zhang N; Holtappels G; Dutré T; Bachert C
J Cyst Fibros; 2012 May; 11(3):193-200. PubMed ID: 22178076
[TBL] [Abstract][Full Text] [Related]
15. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis.
Noah TL; Black HR; Cheng PW; Wood RE; Leigh MW
J Infect Dis; 1997 Mar; 175(3):638-47. PubMed ID: 9041336
[TBL] [Abstract][Full Text] [Related]
16. Elemental content of airway surface liquid from infants with cystic fibrosis.
Hull J; Skinner W; Robertson C; Phelan P
Am J Respir Crit Care Med; 1998 Jan; 157(1):10-4. PubMed ID: 9445271
[TBL] [Abstract][Full Text] [Related]
17. Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis.
Noah TL; Murphy PC; Alink JJ; Leigh MW; Hull WM; Stahlman MT; Whitsett JA
Am J Respir Crit Care Med; 2003 Sep; 168(6):685-91. PubMed ID: 12829455
[TBL] [Abstract][Full Text] [Related]
18. [Myeloperoxidase (MPO) as a marker of neutrophil influx into nasal mucosa after recombinant IL-8 challenge].
Kupczyk M; Bocheńska-Marciniak M; Górski P; Kuna P
Pneumonol Alergol Pol; 2002; 70(11-12):544-9. PubMed ID: 12884563
[TBL] [Abstract][Full Text] [Related]
19. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
[TBL] [Abstract][Full Text] [Related]
20. Comparison of inflammatory elements in nasal lavage and induced sputum following occupational exposure to moldy-building microbes.
Purokivi M; Hirvonen MR; Roponen M; Randell J; Vahteristo M; Tukiainen H
Inhal Toxicol; 2002 Jun; 14(6):653-62. PubMed ID: 12119074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
